Suppr超能文献

Adjuvant Pembrolizumab in Renal-Cell Carcinoma.

作者信息

Chakiryan Nicholas H, Strother Marshall C

机构信息

Oregon Health and Science University, Portland, OR

出版信息

N Engl J Med. 2024 Jul 11;391(2):185-186. doi: 10.1056/NEJMc2406031.

Abstract
摘要

相似文献

1
Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med. 2024 Jul 11;391(2):185-186. doi: 10.1056/NEJMc2406031.
2
Adjuvant Pembrolizumab in Renal-Cell Carcinoma. Reply.
N Engl J Med. 2024 Jul 11;391(2):186. doi: 10.1056/NEJMc2406031.
4
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391.
5
Overall survival with adjuvant pembrolizumab in renal cell carcinoma - the shock of the lightning.
Nat Rev Urol. 2024 Oct;21(10):578-579. doi: 10.1038/s41585-024-00896-6.
6
Adjuvant pembrolizumab improves overall survival in patients with RCC.
Nat Rev Clin Oncol. 2024 Jul;21(7):484. doi: 10.1038/s41571-024-00901-2.
8
Axitinib-ICIs boost the RCC armamentarium.
Nat Rev Clin Oncol. 2019 Apr;16(4):207. doi: 10.1038/s41571-019-0193-5.
9
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695.
10
Pembrolizumab: first adjuvant immunotherapy in renal cell carcinoma?
Future Oncol. 2022 Feb;18(5):519-522. doi: 10.2217/fon-2021-1309. Epub 2022 Jan 24.

引用本文的文献

1
Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma.
World J Surg Oncol. 2025 Jun 20;23(1):243. doi: 10.1186/s12957-025-03897-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验